Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kleinberg

Showing results (441-450 of 645) with videos related to

Pageof 65
Sort By:
Journal of Radiation Oncology|October 4, 2016
Outcome of Adult Brain Tumor Consortium (ABTC) prospective dose-finding trials of I-125 balloon brachytherapy in high-grade gliomas: challenges in clinical trial design and technology development when MRI treatment effect and recurrence appear similarL R Kleinberg, V Stieber, T Mikkelsen, et al.
The Journal of Clinical Endocrinology and Metabolism|April 14, 2005
A critical analysis of pituitary tumor shrinkage during primary medical therapy in acromegalyShlomo Melmed, Richard Sternberg, David Cook, et al.
Neurosurgery Clinics of North America|March 11, 2023
Neurosurgical Applications of Magnetic Hyperthermia TherapyDaniel Rivera, Alexander J Schupper, Alexandros Bouras, et al.
International Journal of Particle Therapy|June 13, 2025
Optimizing QACT Frequency and Setup Uncertainty in Cranial Proton Therapy for Normal Tissue SparingRachel B Ger, Anh Tran, Victoria J Croog, et al.
International Journal of Radiation Oncology, Biology, Physics|March 15, 2016
Eastern Cooperative Oncology Group and American College of Radiology Imaging Network Randomized Phase 2 Trial of Neoadjuvant Preoperative Paclitaxel/Cisplatin/Radiation Therapy (RT) or Irinotecan/Cisplatin/RT in Esophageal Adenocarcinoma: Long-Term Outcome and Implications for Trial DesignLawrence R Kleinberg, Paul J Catalano, Arlene A Forastiere, et al.
Neurosurgical Focus|August 1, 2023
Epidemiology and survival outcomes of synchronous and metachronous brain metastases: a retrospective population-based studyKelly Jiang, Megan Parker, Joshua Materi, et al.
Neurosurgery|June 5, 2020
A Prospective Cohort Study of Neural Progenitor Cell-Sparing Radiation Therapy Plus Temozolomide for Newly Diagnosed Patients With GlioblastomaChengcheng Gui, Tracy D Vannorsdall, Lawrence R Kleinberg, et al.
Journal of Neuro-Oncology|February 18, 2011
A radiotherapy technique to limit dose to neural progenitor cell niches without compromising tumor coverageKristin J Redmond, Pragathi Achanta, Stuart A Grossman, et al.
Molecular Endocrinology (Baltimore, Md.)|October 15, 2005
SOM230 inhibits insulin-like growth factor-I action in mammary gland development by pituitary independent mechanism: mediated through somatostatin subtype receptor 3?Weifeng Ruan, Fabian Fahlbusch, David R Clemmons, et al.
Plos One|August 24, 2023
Kynurenic acid, a key L-tryptophan-derived metabolite, protects the heart from an ischemic damageEinat Bigelman, Metsada Pasmanik-Chor, Bareket Dassa, et al.
Pageof 65

Showing results (441-450 of 645) with videos related to

Sort By:
Pageof 65
Journal of Radiation Oncology|October 4, 2016
Outcome of Adult Brain Tumor Consortium (ABTC) prospective dose-finding trials of I-125 balloon brachytherapy in high-grade gliomas: challenges in clinical trial design and technology development when MRI treatment effect and recurrence appear similarL R Kleinberg, V Stieber, T Mikkelsen, et al.
The Journal of Clinical Endocrinology and Metabolism|April 14, 2005
A critical analysis of pituitary tumor shrinkage during primary medical therapy in acromegalyShlomo Melmed, Richard Sternberg, David Cook, et al.
Neurosurgery Clinics of North America|March 11, 2023
Neurosurgical Applications of Magnetic Hyperthermia TherapyDaniel Rivera, Alexander J Schupper, Alexandros Bouras, et al.
International Journal of Particle Therapy|June 13, 2025
Optimizing QACT Frequency and Setup Uncertainty in Cranial Proton Therapy for Normal Tissue SparingRachel B Ger, Anh Tran, Victoria J Croog, et al.
International Journal of Radiation Oncology, Biology, Physics|March 15, 2016
Eastern Cooperative Oncology Group and American College of Radiology Imaging Network Randomized Phase 2 Trial of Neoadjuvant Preoperative Paclitaxel/Cisplatin/Radiation Therapy (RT) or Irinotecan/Cisplatin/RT in Esophageal Adenocarcinoma: Long-Term Outcome and Implications for Trial DesignLawrence R Kleinberg, Paul J Catalano, Arlene A Forastiere, et al.
Neurosurgical Focus|August 1, 2023
Epidemiology and survival outcomes of synchronous and metachronous brain metastases: a retrospective population-based studyKelly Jiang, Megan Parker, Joshua Materi, et al.
Neurosurgery|June 5, 2020
A Prospective Cohort Study of Neural Progenitor Cell-Sparing Radiation Therapy Plus Temozolomide for Newly Diagnosed Patients With GlioblastomaChengcheng Gui, Tracy D Vannorsdall, Lawrence R Kleinberg, et al.
Journal of Neuro-Oncology|February 18, 2011
A radiotherapy technique to limit dose to neural progenitor cell niches without compromising tumor coverageKristin J Redmond, Pragathi Achanta, Stuart A Grossman, et al.
Molecular Endocrinology (Baltimore, Md.)|October 15, 2005
SOM230 inhibits insulin-like growth factor-I action in mammary gland development by pituitary independent mechanism: mediated through somatostatin subtype receptor 3?Weifeng Ruan, Fabian Fahlbusch, David R Clemmons, et al.
Plos One|August 24, 2023
Kynurenic acid, a key L-tryptophan-derived metabolite, protects the heart from an ischemic damageEinat Bigelman, Metsada Pasmanik-Chor, Bareket Dassa, et al.
Pageof 65